Work

Idiopathic Pulmonary Fibrosis: Current Pathogenetic Insights and Emerging Therapeutic Strategies

Year: 2025

Type: article

Abstract: Idiopathic interstitial pneumonias (IIPs) comprise a heterogeneous group of diffuse parenchymal lung disorders, with idiopathic pulmonary fibrosis (IPF) being the most prevalent subtype. Despite its rarity, IPF is associated with a high mortality rate, driving substantial research into its etiology, pathogenesis, diagnostic strategies, and therapeutic interventions. In recent years, multiple novel agents, including the anti-fibrotic candidate PRM-151, have been explored as potential treatments aimed at modifying disease progression and improving patient outcomes.

Source: International Journal of Biology and Life Sciences

DOI: 10.54097/z5p20r16

Author: Jiying Lou

Institution: University College London

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4413722819

FWCI:

Cites:

Cited by:

Related to: 10